hotspot -WSS

hotspot

author：explore 2025-10-02 21:05:52 - browse：391

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： People with substance use disorder deserve online privacy

WSS

Hospitals are dialing back on venture capital investing

After Optum profits sink, UnitedHealth makes changes

Biogen’s boardroom scandal saddles CEO with first crisis

Dozens dead from Maui wildfires: What we know about the victims

BMS, looking to build heart drug business, turns to AI for diagnosis

Dozens dead from Maui wildfires: What we know about the victims

explore

hotspot

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

YouTube cracks down on misinformation on cancer treatment

Alkermes shareholders re

Senators push IRS to launch nonprofit hospital probe

Tori Bowie and the unacceptable rates of Black maternal death

Transgender sports debate: Physicians say bans are health issue

DIEP, the 'gold standard' of breast reconstruction, is under threat

Patients, doctors press FTC to beef up hospital merger scrutiny

Affirmative action in medical school literally saved lives

Neurocrine congenital adrenal hyperplasia trial succeeds

knowledge

Biden administration begins canceling student loan debt for 804,000 borrowers

Maui wildfire now ranks as the fifth

Judge sides with young activists in first

Timeline: How the deadly wildfires took over Maui day by day

Indictment alleges Trump's ex

Novo Nordisk touts Wegovy study, but still struggling with supply

leisure time

entertainment

entertainment

explore